Recap: Burning Rock Biotech Q2 Earnings

Recap: Burning Rock Biotech Q2 Earnings


Burning Rock Biotech BNR reported its Q2 earnings results on Wednesday, August 31, 2022 at 05:30 AM.

Here's what investors need to know about the announcement.


Burning Rock Biotech missed estimated earnings by 5.71%, reporting an EPS of $-0.37 versus an estimate of $-0.35.

Revenue was down $179 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 1.67% drop in the share price the next day.

Here's a look at Burning Rock Biotech's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.36 -0.27 -0.25 -0.15
EPS Actual -0.39 -0.38 -0.25 -0.30
Revenue Estimate 20.81M 21.47M 20.15M 21.41M
Revenue Actual 21.38M 23.12M 19.65M 19.71M

To track all earnings releases for Burning Rock Biotech visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings